Clinical Trial Update: Rectal Misoprostol in Women Undergoing Myomectomy for Intraoperative Blood Loss: A Randomized Placebo-controlled Study [Phase 4]

View source ↗

Summary

A Phase 4 randomized, placebo-controlled trial assessing rectal misoprostol to reduce intraoperative blood loss in women undergoing myomectomy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uterine Fibroids

Drugs mentioned

• Misoprostol (rectal) (misoprostol)

Snippet

Sponsor: Department of Medical Services Ministry of Public Health of Thailand | Conditions: Misoprostol, Blood Loss, Myomectomy | Phase 4 | Status: COMPLETED